Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine. [electronic resource]
Producer: 20050621Description: 367-75 p. digitalISSN:- 1042-8194
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cytarabine -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Leukemia, Myeloid, Acute -- classification
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Patient Selection
- Pilot Projects
- Prognosis
- Remission Induction
- Survival Analysis
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.